In other countries
The same active substances on other registers, the same brand first.
- Xydalba 500 MG de Polvo Para Concentrado Para Solucion Para PerfusionSpain · 516 mg · polvo para concentrado para solución para perfusión · Abbvie Deutschland Gmbh & Co. KgSame brand
- XydalbaEuropean Union · AbbVie Deutschland GmbH & Co. KGSame brand
- XydalbaCroatiaSame brand
- XydalbaItaly · Polvere per concentrato per soluzione per infusione · Abbvie Deutschland GMBH & Co. KGSame brand
- Xydalba 500 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · AbbVie Deutschland GmbH & Co. KGSame brand
- XYDALBA 500 mgRomania · 500mg · pulb. pt. conc. pt. sol. perf. · Allergan Pharmaceuticals International LTD.Same brand
- XYDALBA 500mgRomania · 500mg · pulb. pt. conc. pt. sol. perf. · Durata Therapeutics International BVSame brand
- Dalbavancin HydrochlorideUnited States · 500MG BASE/VIAL · powder · Be PharmsSame strength and form
- DalvanceUnited States · 500MG BASE/VIAL · powder · AbbvieSame strength and form
- Dalbavancina Accord 500 MG Polvo Para Concentrado Para Solucion Para Perfusion EfgSpain · 500 mg · polvo para concentrado para solución para perfusión · Accord Healthcare S.L.U.Same substance
- Dalbavancina Advanz Pharma 500 MG Polvo Para Concentrado Para Solucion Para Perfusion EfgSpain · 516 mg · polvo para concentrado para solución para perfusión · Advanz Pharma LimitedSame substance
- Dalbavancina AccordItaly · Polvere per concentrato per soluzione per infusione · Accord Healthcare, S.L.U.Same substance
- Dalbavancina BaxterItaly · Polvere per concentrato per soluzione per infusione · Baxter Holding BVSame substance
- Dalbavancine Baxter 500 mg poeder voor concentraat voor oplossing voor infusieNetherlands · Poeder voor concentraat voor oplossing voor infusie · Baxter B.V.Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Dalbavancin
- Strength
- 500 MG / VIAL
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 28 May 2021
- Registration
- DIN 02480522
- Marketing authorisation holder
- Knight Therapeutics INC.
- ATC code
- J01XA04
- Supply
- PRESCRIPTION